|
US20070014787A1
(en)
*
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
|
US7479555B2
(en)
|
1999-07-21 |
2009-01-20 |
Ceres, Inc. |
Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US7431923B2
(en)
|
2005-01-03 |
2008-10-07 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7442777B2
(en)
|
2000-11-29 |
2008-10-28 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7534429B2
(en)
|
2000-11-29 |
2009-05-19 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
AU2002332929A1
(en)
|
2001-09-07 |
2003-03-24 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
|
|
WO2004013311A2
(en)
*
|
2002-08-06 |
2004-02-12 |
Diadexus, Inc. |
Compositions and methods relating to ovarian specific genes and proteins
|
|
US20050037946A1
(en)
*
|
2003-01-13 |
2005-02-17 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
|
|
US7094572B2
(en)
|
2003-03-14 |
2006-08-22 |
Bristol-Myers Squibb |
Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
WO2005019258A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
WO2005121778A2
(en)
*
|
2004-06-14 |
2005-12-22 |
Galapagos N.V. |
Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
|
|
US8288119B2
(en)
|
2004-06-21 |
2012-10-16 |
Exelixis, Inc. |
PGDS as modifiers of the PTEN pathway and methods of use
|
|
JPWO2006006477A1
(ja)
*
|
2004-07-09 |
2008-04-24 |
国立大学法人三重大学 |
骨疾患又は関節疾患に関与するポリペプチド及びそのｄｎａ
|
|
JP2008506639A
(ja)
*
|
2004-07-16 |
2008-03-06 |
ヴァル−シュム・エス・ウ・セ |
血栓性事象を阻害または軽減するラミンｂ１核抗原、そのフラグメントおよび組成物の使用の方法
|
|
WO2006072946A2
(en)
*
|
2005-01-04 |
2006-07-13 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
|
|
WO2006091676A2
(en)
|
2005-02-22 |
2006-08-31 |
Ceres Inc. |
Modulating plant alkaloids
|
|
EP1851543A2
(en)
|
2005-02-24 |
2007-11-07 |
Compugen Ltd. |
Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
|
|
GB0510627D0
(en)
|
2005-05-25 |
2005-06-29 |
Avidex Ltd |
Polypeptides
|
|
WO2006133461A1
(en)
|
2005-06-08 |
2006-12-14 |
Ceres Inc. |
Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
|
|
CA2618951A1
(en)
*
|
2005-08-12 |
2007-02-22 |
Schering Corporation |
Mcp1 fusions
|
|
GB0519376D0
(en)
*
|
2005-09-23 |
2005-11-02 |
Astrazeneca Ab |
Diagnostic method
|
|
US8110184B2
(en)
*
|
2005-09-30 |
2012-02-07 |
University Of Kentucky Research Foundation |
Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations
|
|
EP1945754B1
(en)
|
2005-10-31 |
2014-07-23 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070192885A1
(en)
*
|
2006-01-26 |
2007-08-16 |
Daniel Chelsky |
TAT-039 and methods of assessing and treating cancer
|
|
JP5146944B2
(ja)
*
|
2006-03-20 |
2013-02-20 |
独立行政法人理化学研究所 |
Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御
|
|
EP2014297B1
(en)
*
|
2006-03-20 |
2013-03-13 |
Japan Science and Technology Agency |
Control of intracellular target molecule by ip3 receptor-binding protein
|
|
KR20090013763A
(ko)
|
2006-03-23 |
2009-02-05 |
기린 파마 가부시끼가이샤 |
인간 트롬보포이에틴 수용체에 대한 아고니스트 항체
|
|
US20070237713A1
(en)
|
2006-04-04 |
2007-10-11 |
Fan Rong A |
PCan065 Antibody Compositions and Methods of Use
|
|
US7919092B2
(en)
*
|
2006-06-13 |
2011-04-05 |
Oncomed Pharmaceuticals, Inc. |
Antibodies to notch receptors
|
|
JP4997547B2
(ja)
*
|
2006-06-15 |
2012-08-08 |
独立行政法人理化学研究所 |
炎症性疾患の判定方法
|
|
FR2908654B1
(fr)
|
2006-11-20 |
2014-04-04 |
Oreal |
Utilisation cosmetique de proteines de type chitinase
|
|
WO2008065397A2
(en)
*
|
2006-11-29 |
2008-06-05 |
Medical Research Council |
Assay
|
|
WO2008079406A2
(en)
*
|
2006-12-19 |
2008-07-03 |
Genentech, Inc. |
Gene expression markers for inflammatory bowel disease
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
CA2676008A1
(en)
|
2007-01-24 |
2008-07-31 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
WO2008092214A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Minomic International Limited |
Biomarkers for diabetes
|
|
US20090208491A1
(en)
*
|
2007-02-14 |
2009-08-20 |
Austin Gurney |
Compositions and Methods for Diagnosing and Treating Cancer
|
|
JP5378202B2
(ja)
*
|
2007-03-15 |
2013-12-25 |
株式会社リバース・プロテオミクス研究所 |
脳・神経に特異的あるいは神経分化に特異的なバイオマーカー
|
|
WO2008156685A2
(en)
*
|
2007-06-14 |
2008-12-24 |
Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health |
Tendon stem cells
|
|
JP2010537952A
(ja)
*
|
2007-08-24 |
2010-12-09 |
マイレクサ ピーティーワイ リミテッド |
過敏症反応の調節因子
|
|
JP2009055838A
(ja)
*
|
2007-08-31 |
2009-03-19 |
Nipro Corp |
融合タンパク質、該融合タンパク質に関連する遺伝子、ベクター、形質転換体及び抗炎症性医薬組成物
|
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
|
US9132189B2
(en)
|
2008-07-08 |
2015-09-15 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
EP2899211A1
(en)
|
2008-07-08 |
2015-07-29 |
OncoMed Pharmaceuticals, Inc. |
Notch1 receptor binding agents and methods of use thereof
|
|
MX341149B
(es)
|
2008-10-10 |
2016-08-09 |
Amgen Inc |
Mutantes fgf21 y uso de los mismos.
|
|
MX2011004467A
(es)
|
2008-10-31 |
2011-07-28 |
Biogen Idec Inc |
Moleculas de objetivo light y usos de las mismas.
|
|
CN102239414A
(zh)
|
2008-12-04 |
2011-11-09 |
赛诺菲-安万特 |
牵涉血红素结合蛋白1的方法和用途
|
|
WO2010067308A2
(en)
|
2008-12-08 |
2010-06-17 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
|
JP2012525847A
(ja)
|
2009-05-05 |
2012-10-25 |
アムジエン・インコーポレーテツド |
Ｆｇｆ２１変異体およびその使用
|
|
LT3248610T
(lt)
|
2009-05-05 |
2024-01-25 |
Amgen Inc. |
Fgf21 mutantai ir jų panaudojimas
|
|
WO2010129890A2
(en)
*
|
2009-05-08 |
2010-11-11 |
Virginia Tech Intellectual Properties, Inc. |
Compounds and methods for inhibiting platelet aggregation
|
|
WO2010141999A1
(en)
*
|
2009-06-12 |
2010-12-16 |
The University Of Queensland |
Agents and methods for diagnosing and treating ankylosing spondylitis
|
|
EP2443145A1
(en)
|
2009-06-17 |
2012-04-25 |
Amgen, Inc |
Chimeric fgf19 polypeptides and uses thereof
|
|
SMT201700248T1
(it)
|
2009-11-02 |
2017-07-18 |
Univ Washington |
Composizioni terapeutiche di nucleasi e metodi
|
|
JP2013512672A
(ja)
*
|
2009-12-02 |
2013-04-18 |
アムジエン・インコーポレーテツド |
ヒトＦＧＦＲ１ｃ、ヒトβ−クロト−、ならびにヒトＦＧＦＲ１ｃおよびヒトβ−クロト−の両方に結合する結合タンパク質
|
|
UA109888C2
(uk)
*
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
MX2012008085A
(es)
|
2010-01-13 |
2012-09-12 |
Oncomed Pharm Inc |
Agentes de union notch1 y metodos de uso de los mismos.
|
|
WO2011093176A2
(en)
|
2010-01-28 |
2011-08-04 |
Canon Kabushiki Kaisha |
Scintillator crystal body, method for manufacturing the same, and radiation detector
|
|
CA2695337A1
(en)
*
|
2010-03-04 |
2011-09-04 |
Ian De Belle |
Compositions and methods for inhibition of hiv
|
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|
|
EP2975134A3
(en)
|
2010-07-22 |
2016-02-24 |
Shire Human Genetic Therapies, Inc. |
Crystal structure of human alpha-n-acetylglucosaminidase
|
|
EP3578568A3
(en)
|
2010-11-08 |
2020-01-08 |
Ablynx N.V. |
Cxcr2 binding polypeptides
|
|
US20140056811A1
(en)
*
|
2010-12-27 |
2014-02-27 |
Compugen Ltd. |
New cell-penetrating peptides and uses thereof
|
|
IT1406405B1
(it)
*
|
2010-12-27 |
2014-02-21 |
Univ Roma |
Molecole peptidiche per il trattamento di patologie mitocondriali
|
|
ES2666303T3
(es)
|
2011-04-29 |
2018-05-03 |
University Of Washington |
Composiciones terapéuticas de nucleasa y métodos
|
|
SG194883A1
(en)
*
|
2011-05-13 |
2013-12-30 |
Inst Nat Sante Rech Med |
Method for the diagnosis of early rheumatoid arthritis
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
RU2015116480A
(ru)
|
2012-11-07 |
2016-12-27 |
Пфайзер Инк. |
Анти-notch3 антитела и конъюганты антител с лекарственным средством
|
|
MX370720B
(es)
|
2012-12-21 |
2019-12-20 |
Aveo Pharmaceuticals Inc |
Anticuerpos anti-gdf15.
|
|
WO2014141064A1
(en)
|
2013-03-13 |
2014-09-18 |
Novartis Ag |
Notch2 binding molecules for treating respiratory diseases
|
|
SI3063275T1
(sl)
|
2013-10-31 |
2020-02-28 |
Resolve Therapeutics, Llc |
Terapevtske fuzije nukleaza-albumin in postopki
|
|
US20160324944A1
(en)
*
|
2013-12-29 |
2016-11-10 |
Franco Venanzi |
Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
|
|
US10155008B2
(en)
*
|
2014-04-18 |
2018-12-18 |
Yantai Jujie Bioengineering Limited Company |
Use of 15 male fertility related proteins or combination thereof
|
|
SG11201700901SA
(en)
|
2014-08-08 |
2017-03-30 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
GB201508025D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Fabry disease gene therapy
|
|
WO2017184951A1
(en)
|
2016-04-22 |
2017-10-26 |
Vaccinex, Inc. |
Integral membrane protein display on poxvirus extracellular enveloped virions
|
|
MA45554A
(fr)
|
2016-07-01 |
2019-05-08 |
Resolve Therapeutics Llc |
Fusions de binucléase optimisées.
|
|
KR102033215B1
(ko)
*
|
2016-07-05 |
2019-10-16 |
성균관대학교산학협력단 |
건선 유발 동물 모델 및 이의 용도
|
|
GB201700567D0
(en)
|
2017-01-12 |
2017-03-01 |
Genagon Therapeutics Ab |
Therapeutic agents
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
CN111093641A
(zh)
|
2017-05-24 |
2020-05-01 |
托埃瑞斯有限责任公司 |
谷氨酰胺合成酶用于治疗高氨血症的用途
|
|
CN119192376A
(zh)
|
2017-08-03 |
2024-12-27 |
艾利妥 |
抗trem2抗体和其使用方法
|
|
SG11202001311VA
(en)
|
2017-08-22 |
2020-03-30 |
Sanabio Llc |
Soluble interferon receptors and uses thereof
|
|
US12274733B2
(en)
|
2018-09-28 |
2025-04-15 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
WO2020069373A1
(en)
|
2018-09-28 |
2020-04-02 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
US20210388345A1
(en)
*
|
2018-10-22 |
2021-12-16 |
Roche Sequencing Solutions, Inc. |
Profiling of rheumatoid arthritis autoantibody repertoire and peptide classifiers therefor
|
|
WO2020178426A1
(en)
*
|
2019-03-07 |
2020-09-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New vaccinal strategy to prevent or treat rheumatoid arthritis
|
|
US20230059560A1
(en)
*
|
2020-01-21 |
2023-02-23 |
Boehringer Ingelheim International Gmbh |
Myeloid-derived growth factor for use in treating or preventing fibrosis, hypertrophy or heart failure
|
|
US20250270278A1
(en)
*
|
2020-12-07 |
2025-08-28 |
The Research Foundation For The State University Of New York |
Methods of making water-soluble protein formed in a bacterial expression system, compositions, and methods of use thereof
|
|
US12252518B2
(en)
|
2023-01-06 |
2025-03-18 |
Life Biosciences, Inc. |
Methods of treating non-arteritic anterior ischemic optic neuropathy
|
|
WO2024231931A1
(en)
*
|
2023-05-08 |
2024-11-14 |
Canopy Immuno-Therapeutics Ltd. |
Ig-like fusion proteins for treating immune thrombocytopenia
|
|
WO2025075975A1
(en)
*
|
2023-10-02 |
2025-04-10 |
Matice BioSciences, Inc. |
Peptides from regenerative species and methods for use thereof
|